Refreshing results…
Trial of Beremagene Geperpavec (B-VEC) for Dystrophic Epidermolysis Bullosa
UploadIn vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial
UploadMissing publications? Search for publications with a matching author name.